Vivus (VVUS) Rising on New Drug Prospect
1:00pm (EST) Vivus (VVUS, $8.40, up $0.32) is back in the spotlight but this time it’s not for news concerning
BioTech, Daily Update
Vivus
Daily Update, Market Analysis, Company Commentary
Futures Pointing Towards Lower Start
9:00am (EST) The bulls got a curve ball before the closing bell and had their four-session winning streak snapped as the market
Market Analysis, BioTech, Daily Update, Earnings
Goldman Sachs (GS) Settles, Google (GOOG) Misses, Vivus (VVUS) Gets Slammed
9:00am (EST) We’ve got a long way to go and a short time to get there… There is so much
Market Analysis, Market Commentary, BioTech, Daily Update, Earnings
Bears See An Opening
1:00pm (EST) The bulls are having a tough day and you don’t need us to tell you the market may
Market Analysis, Market Commentary, Daily Update, IPOs
Rally Stalls After Weak Retail Sales
1:00pm (EST) When we shut our eyes this morning around 2am, the Dow futures were up 70 points and it
Company Commentary, BioTech, Daily Update, Earnings
Bulls Resting, Will Bears Show Up Next Week?
1:00pm (EST) The market has traded in a tight range although the bulls are still the fat kid on the
Daily Update, Company Commentary, BioTech
Vivus (VVUS) Back Peddles On New Concerns
1:00pm (EST) The market is trading in a tight range as the bulls try to push the Dow higher for
Daily Update, Sectors, Market Analysis, Oil, Market Commentary, Company Commentary, Trading Tips, Option Trades
Eye On The Prize
9:00am (EST) It is amazing the price swings stocks and options can go through. The best part about being an
Daily Update, Market Analysis, Company Commentary
Bulls Looking For Momentum
9:05am (EST) The market got off to a good start for 2010 as the Dow rallied 155 points to close
Daily Update, Company Commentary
Orexigen Therapeutics Up Sharply After-Hours
Orexigen Therapeutics (OREX, $5.89, down $0.10) was up sharply in after-hours trading on news that the company could be announcing